Oncology Central

Targeted therapy in metastatic colon cancer


Colorectal cancer, the third leading cause of cancer and cancer-related mortality in both men and women in the USA, is certainly a major public health concern. The annual incidence of colorectal cancer has increased from 130,200 in 2000 to 142,820 in 2013 [1,2]. In 2000, it accounted for a total of 56,300 deaths, whereas in 2013, the number of estimated deaths slightly declined to an estimated 50,830 individuals [12].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.